Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients
…, E Dansin, M Pérol, M Campana… - European …, 2017 - Eur Respiratory Soc
Immunotherapy is becoming a standard of care for many cancers. Immune-checkpoint
inhibitors (ICI) can generate immune-related adverse events. Interstitial lung disease (ILD) has …
inhibitors (ICI) can generate immune-related adverse events. Interstitial lung disease (ILD) has …
Coronary toxicities of anti-PD-1 and anti-PD-L1 immunotherapies: a case report and review of the literature and international registries
…, C Pageot, T Bejan-Angoulvant, M Campana… - Targeted Oncology, 2018 - Springer
Immunotherapy medications that target programmed death 1 protein (PD-1) and programmed
death-ligand 1 (PD-L1), such as nivolumab, pembrolizumab, and atezolizumab, are …
death-ligand 1 (PD-L1), such as nivolumab, pembrolizumab, and atezolizumab, are …
Recommandations pratiques pour le diagnostic et la prise en charge de la fibrose pulmonaire idiopathique–Actualisation 2021. Version intégrale
…, B Trumbic, K Berkani, PY Brillet, M Campana… - Revue des Maladies …, 2022 - Elsevier
Background Since the previous French guidelines were published in 2017, substantial
additional knowledge about idiopathic pulmonary fibrosis has accumulated. Methods Under the …
additional knowledge about idiopathic pulmonary fibrosis has accumulated. Methods Under the …
[HTML][HTML] The clinical course of interstitial lung disease in an adult patient with an ABCA3 homozygous complex allele under hydroxychloroquine and a review of the …
…, S Chantot-Bastaraud, M Campana… - … Vasculitis, and Diffuse …, 2022 - ncbi.nlm.nih.gov
Objective: The gene mutations responsible for ABCA3 protein deficiency are involved in
respiratory distress of the newborn and much more rarely in adult interstitial lung diseases (ILD). …
respiratory distress of the newborn and much more rarely in adult interstitial lung diseases (ILD). …
French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis–2021 update. Full-length version
…, B Trumbic, K Berkani, PY Brillet, M Campana… - … Medicine and Research, 2023 - Elsevier
Background Since the latest 2017 French guidelines, knowledge about idiopathic pulmonary
fibrosis has evolved considerably. Methods Practical guidelines were drafted on the …
fibrosis has evolved considerably. Methods Practical guidelines were drafted on the …
Difficulties encountered by general practitioners during acute behavioral disturbances of their dementia patients.
M Campana, S Bonin-Guillaume… - Geriatrie et …, 2016 - europepmc.org
Alzheimer diseases and related disorders (ADRD) remain a major public health issue. The
progression of the disease is dominated by behavioral and psychological symptoms of …
progression of the disease is dominated by behavioral and psychological symptoms of …
French practical guidelines for the diagnosis and management of IPF-2021 update, full version
…, K Berkani, PY Brillet, M Campana… - Revue des Maladies …, 2022 - europepmc.org
Background Since the previous French guidelines were published in 2017, substantial
additional knowledge about idiopathic pulmonary fibrosis has accumulated. Methods Under the …
additional knowledge about idiopathic pulmonary fibrosis has accumulated. Methods Under the …
A panchromatic view of the restless SN 2009ip reveals the explosive ejection of a massive star envelope
The double explosion of SN 2009ip in 2012 raises questions about our understanding of the
late stages of massive star evolution. Here we present a comprehensive study of SN 2009ip …
late stages of massive star evolution. Here we present a comprehensive study of SN 2009ip …
High Prevalence of Vulvar and Hepatic Manifestations in a Series of 18 Histiocytosis with Brafdel Mutations
…, S Bota, LS Vanessa, S Dominique, M Campana… - Blood, 2023 - Elsevier
Introduction L-group histiocytosis (Erdheim-Chester disease (ECD) and Langerhans-cell
histiocytosis (LCH)) are multi-system diseases characterized by histiocyte infiltration in several …
histiocytosis (LCH)) are multi-system diseases characterized by histiocyte infiltration in several …
Intérêts du biomarqueur CA 15-3 au cours de la fibrose pulmonaire idiopathique
M Campana, M Ghanem, L Plantier, D Dufour… - Revue des Maladies …, 2017 - Elsevier
Introduction La fibrose pulmonaire idiopathique (FPI) est une maladie fibroproliférative dont l’évolution
est habituellement progressive et irréversible. De nouvelles molécules …
est habituellement progressive et irréversible. De nouvelles molécules …